cellular
• reduced migration of encephalitogenic CD4+ T cells from MOG-treated mice toward chemokine Cxcl12 in vitro
• reduced number of CD4+ cells in CNS after MOG peptide-induced experimental autoimmune encephalomyelitis
|
hematopoietic system
• reduced migration of encephalitogenic CD4+ T cells from MOG-treated mice toward chemokine Cxcl12 in vitro
• reduced number of CD4+ cells in CNS after MOG peptide-induced experimental autoimmune encephalomyelitis
|
immune system
N |
• numbers of CD4+ T cells in spleen and draining LNs during induction of EAE with MOG same as in similarly treated wild-type mice
|
• reduced migration of encephalitogenic CD4+ T cells from MOG-treated mice toward chemokine Cxcl12 in vitro
• reduced number of CD4+ cells in CNS after MOG peptide-induced experimental autoimmune encephalomyelitis
|
• reduced clinical scores after MOG (35-55) peptide-induced EAE
• encephalitogenic CD4+ T cells from MOG-treated mice fail to cause disease when transplanted into sub-lethally irradiated WT recipient mice
|